DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
144.77
-6.55 (-4.33%)
Jul 24, 2025, 4:00 PM - Market closed

Company Description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.

It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services.

Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business.

The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016.

DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DaVita Inc.
DaVita logo
CountryUnited States
Founded1994
IPO DateOct 31, 1995
IndustryMedical Care Facilities
SectorHealthcare
Employees76,000
CEOJavier Rodriguez

Contact Details

Address:
2000 16th Street
Denver, Colorado 80202
United States
Phone720-631-2100
Websitedavita.com

Stock Details

Ticker SymbolDVA
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000927066
CUSIP Number23918K108
ISIN NumberUS23918K1088
Employer ID51-0354549
SIC Code8090

Key Executives

NamePosition
Javier J. RodriguezChief Executive Officer and Executive Director
Joel AckermanChief Financial Officer and Treasurer
David P. MaughanChief Operating Officer of Kidney Care
Kathleen Alyce WatersChief Legal and Public Affairs Officer
James O. HeartyChief Compliance Officer
Christopher Michael Berry CPAGroup Vice President and Chief Accounting Officer
Madhu NarasimhanChief Information Officer
Nic EliasonGroup Vice President of Investor Relations
Jessica HergenreterChief People Officer
Misha PalecekChief Transformation Officer of U.S. Kidney Care Business

Latest SEC Filings

DateTypeTitle
Jul 23, 2025144Filing
Jul 17, 20258-KCurrent Report
Jun 13, 202511-KAnnual report of employee stock purchase, savings and similar plans
Jun 9, 20258-KCurrent Report
May 23, 20258-KCurrent Report
May 20, 20258-KCurrent Report
May 20, 20258-KCurrent Report
May 12, 202510-QQuarterly Report
May 12, 20258-KCurrent Report
Apr 25, 2025SCHEDULE 13G/AFiling